Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Marta Kruk-Słomka, Agnieszka Michalak, Grażyna Biała
Behavioural Brain Research (2015) Vol. 284, pp. 24-36
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Reinforcement learning in depression: A review of computational research
Chong Chen, Taiki Takahashi, Shin Nakagawa, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 55, pp. 247-267
Closed Access | Times Cited: 200
MicroRNA: Small RNA mediators of the brains genomic response to environmental stress
Sharon L. Hollins, Murray J. Cairns
Progress in Neurobiology (2016) Vol. 143, pp. 61-81
Open Access | Times Cited: 105
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 104
Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain
Jennifer M. Wenzel, Erik B. Oleson, Willard N. Gove, et al.
Current Biology (2018) Vol. 28, Iss. 9, pp. 1392-1404.e5
Open Access | Times Cited: 89
Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus
Ahad Banagozar Mohammadi, Mohammadali Torbati, Fereshteh Farajdokht, et al.
Brain Research (2019) Vol. 1715, pp. 47-56
Closed Access | Times Cited: 76
The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System
Anthony L. Berger, Angela M. Henricks, Janelle M. Lugo, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 8, pp. 611-623
Open Access | Times Cited: 63
Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms
Yasuhisa Ano, Hiroyuki Nakayama
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1927-1927
Open Access | Times Cited: 56
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 27
Antibiofilm and Antivirulence Activities of Gold and Zinc Oxide Nanoparticles Synthesized from Kimchi-Isolated Leuconostoc sp. Strain C2
Min-Gyun Kang, Fazlurrahman Khan, Du-Min Jo, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1524-1524
Open Access | Times Cited: 27
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 13
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access
Potentiation of endocannabinoid signaling alleviates depressive-like behavior in diabetic mice
Anuradha Kesharwani, Devidas Lahamge, Shubhankar Kumar Singh, et al.
Deleted Journal (2025), pp. 100037-100037
Closed Access
Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
Fatemeh Khakpai, Mohaddeseh Ebrahimi-Ghiri, Sakineh Alijanpour, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 112, pp. 108717-108717
Open Access | Times Cited: 41
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rui S. Rodrigues, Diogo M. Lourenço, Sara L. Paulo, et al.
Molecules (2019) Vol. 24, Iss. 7, pp. 1350-1350
Open Access | Times Cited: 39
Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress
Arvin Haj‐Mirzaian, Hossein Amini-Khoei, Arya Haj‐Mirzaian, et al.
Brain Research Bulletin (2017) Vol. 130, pp. 200-210
Closed Access | Times Cited: 38
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors
Helen de Morais, Camila Pasquini de Souza, Luísa Mota da Silva, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 10, pp. 1590-1600
Closed Access | Times Cited: 37
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
Marta Kruk-Słomka, Anna Boguszewska‐Czubara, Tomasz Słomka, et al.
Neural Plasticity (2015) Vol. 2016, pp. 1-15
Open Access | Times Cited: 35
CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice
Marta Kruk-Słomka, Grażyna Biała
Behavioural Brain Research (2015) Vol. 301, pp. 84-95
Closed Access | Times Cited: 35
Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495
Karolina Podkowa, Adrian Podkowa, Kinga Sałat, et al.
Neuropharmacology (2016) Vol. 111, pp. 169-179
Closed Access | Times Cited: 33
Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement
Joshua A. Bilbrey, Yuma T. Ortiz, Jasmine S. Felix, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1475-1486
Closed Access | Times Cited: 23
Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
Wenjiao Yang, Xudong Gong, Haiguo Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116048-116048
Closed Access | Times Cited: 9
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Isadora Lopes Cortez, Naielly Rodrigues da Silva, Francisco Silveira Guimarães, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 24
Spontaneous Activity of CB2 Receptors Attenuates Stress-Induced Behavioral and Neuroplastic Deficits in Male Mice
Melissa A. Ribeiro, Rafael Pazinatto Aguiar, Franciele Franco Scarante, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 15
Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling
Katarzyna Stachowicz
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105439-105439
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top